Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03326739 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Versus Landmark Guided Arterial Line Placement by Emergency Medicine Interns
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03326739 is a NA study that has completed, run by Temple University. The registered enrollment target is 40 participants.
The verdict
NCT03326739, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Critically ill patients in the emergency department commonly require arterial line placement for continuous direct blood pressure monitoring, frequent arterial blood gas sampling, and frequent blood sampling. Trans-radial catheterization has been shown to reduce access site complications and increase patient comfort compared to trans-femoral access. Radial artery access on the first attempt is optimal; attempts at reentry delay care and increase the risk of vascular spasm, hematoma, infection, neurovascular injury, and pain. The traditional pulse palpation method of radial artery cannulation can be challenging, especially in patients with weak pulses (i.e. morbidly obese or hypotensive individuals). A review of literature suggests that ultrasound guided trans-radial catheterization compared to standard pulse palpation reduces access time and increases rate of first-entry success when performed by physicians trained in ultrasound. Thus, complications ascribed to reentry are prevented and timely care is provided. To the investigator's knowledge, only one other prospective study has been conducted to assess the utility of ultrasound guided radial artery cannulation in the emergency department. Due to the paucity of literature to support the use of ultrasound guided trans-radial catheterization in critically ill patients, the study will aim to provide further data on the topic. Both techniques are considered standard of care.
Interventions
- PROCEDURE Arterial Line Placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03326739
The ClinicalTrials.gov registry entry for NCT03326739 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Arterial Line Placement is the first listed.
NCT03326739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03326739 about?
NCT03326739 is a clinical study titled "Ultrasound Guided Versus Landmark Guided Arterial Line Placement by Emergency Medicine Interns". Critically ill patients in the emergency department commonly require arterial line placement for continuous direct blood pressure monitoring, frequent arterial blood gas sampling, and frequent blood sampling. Trans-radial catheterization has been shown to reduce access site complications and increas...
What is the current status of trial NCT03326739?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-01-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03326739?
The interventions under investigation include: Arterial Line Placement (PROCEDURE).
Who is sponsoring clinical trial NCT03326739?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.